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ABSTRACT

Present concepts of ACTH/cyclic nucleotide regulation
of steroidogenesis involve stimulation, by' either cAf1P or
cGMP, of a protein kinase which in turn removes an inhibitory protein from a pretranscribed mRNA. A cycloheximide
sensitive step between cholesterol and pregnenolone indicates
the requirement of a specific protein at this point.
The
.. activated mRNA is suggested to translate this prote.iln.
The
·
_evidence to support these concepts. remains to be substantiated.
The isolated rat adrenal cell has been used for the assessment of regulatory factors in steroidogenesis.
Isolated adrenal cells were prepared by collagenase digestion and steroidogenesis was evaluated by RIA of corticosterone and thin
layer chromatography from radi·oactive precursors.
The involve.ment of RNA and protein synthesis was evaluated by use .
of the respective inhibitors Actinomycin D and cycloheximide,
and the incorporation of 3H-leucine into proteins. ·corticos.terone production was
dose responsive
and showed an' LDso of
.
.
35 µU of ACTH. With transcription inhibited by 12 pg/ml of
Actinomycin D, no effect was seen on ACTH stimulated corticosterone production. This tends to support the existence.of
a pretranscribed mRNA. Cycloheximide inibition of protein
translation was dose reponsive( 0.1, 1.0, and 1.0 .. 0 µM) when
corticosterone was measured by RIA, however, no' dose of cycloheximide was effective when measuring 3H-pregnenolone conversion after ACTH stimulation. This indicates that a protein
is required, but the requirement is before pregneno~one.
ACTH
stimulation of protein synthesis as measured by 3H-leucine
incorporation, indicates that ACTH and dbcAMP, but riot cAMP
and cGMP, stimulated protein synthesis at the doses used.
This research supports the present theory of ACTH, but does
not clarify the role of cyclic nucleotides in steroidogenesis.
(This research was supported by a faculty research grant from
Morehead State University}.
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INTRODUCTION
'

The mechanism of adrenocorticotropin (ACTH) action
on adrenal cells is thought to be through the classic
1st messenger - 2nd mess·enger pathway first proposed for
the action of epinephrine by Sutherland (1), and later
for the action of ACTH by Haynes and Berthet (2).

After

binding to a highly specific plasma·membrane receptor,
ACTH (1st messenger) activates the membrane

bound

enzyme, adenylate cyclase, which catalyzes the
cytoplasmic conversion of adenosine triphosphate (ATP)
to cyclic-3',S'-adenosine monophosphate (cAMP)
(2, 3, 4).

Cyclic ANP (2nd messenger) activates a

specific protein kinase, an enzyme which transfers a,
phosphate group from ATP to a suggested protein involved
in the activation of steroidogenesis (5).
The formation of corticosterone (B) is summariz.~d· in
Figure 1.

The site of· ACTH: and cAMP stimulation as,

measured by accumulation of labelled B from

radioact~ve

precursors, suggests the rate limiting step of
steroidogenesis in the adrenal cell is between
and 20 oc - hydroxycholesterol (6).

chole~terol

That protein synt)lesis

is involved in this activation is suggested by experimen ts using protein inhibitors, i. e.. cycloheximide and

I

puromycin.

Cycloheximide, a specific inhibitor of
1
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Pathway for glucocorticoid biosynthesis in Jhe
·adrenal cortex.
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protein translation, blocks the stimulation of
steroidogenesis by ACTH and cAMP {7).

•

"1

Th is suggests\

that ACTH acts via cAMP by.stimulating the translation
I
of a protein which acts between cholesterol and 20 cc
hydroxycholesterol.

l

Furthermore, this protein has been

suggested to be derived from a preexisting messenger
RNA (8)

1

and possess a half-life of eight minutes (9).

Recently, · cyclic-3 ', 5' guanosine monophosphate
(cGMP) has been implicated as the 2nd messenger of ACTH
(lQ; 11).

At ve.ry low levels of ACTH, which stimulat;ed

steroidogenesis but did not increase cAMP, cGMP levels
were increased.

This evidence suggests two theories ifor

10echanism of ACTH action.

One, that ACTH is mediated at

low and high o:levels by two different cyclic nucleotides.
Additionally cAMP may be the pharmacological mediator.
· This study proposes to clarify the intracellular:

:

molecular mechanisms .through which ACTH acts upon the,
isolated rat adrenal cell.

Specificaily, an under-

standing of cyclic nucleotides,· the extent of protein)
synthesis involement in steroidogenesis and the time '
.interval between sti.mulation and steroid release· will
be studied.

.'
'
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MATERIALS AND METHODS

I

I
I

Animal care

I

'

I

Female rats of the Sprague-Dawley strain·, 150-18 10
days of·. age, were maintained in animal quarters under' a ·
lighting regimen of 12 hours light:

12 hours dark.

They were given Purina Lab Chow (Ralston-Purina Co.)
ad libi:tum.

An antibiotic drinking solution ·(sulmet

Drinking Solution, American Cyanamid Co.) was added to
their drinking water at a dosage of 30 ml/3.8 liters of
water, given alternately with tap water at every other
watering period.

,.

Rats were stunned, decapitated and exsanguated
within one miriute after their removal from·the animal'.
room.

The adrenals were removed and placed .on saline'.

.moistened filter paper in a petri dish on ice.

After'

all adrenals had been collected, they were brought to
the la·b where they were placed on a chilled glass plaj:e,
trimmed of excess fat with a razor blade, and cut into
eights.

Pooled adrenals were rinsed with 10 ml of cold

Krebs Ringer Bicarbonate buffer to which 200 mg% glucose
was added . (KRBG l ·.

5

Isol·ation of Adren·a1 ce1·1s
All glassware used in the isolation procedure w~s
I
.silicontreated (Siliclad, Clay-Adams). Double disti!led
I
I

water and redistilled organ:Lc solvents were used

!

'

throughout the procedure .
.Isolated adrenal cells were prepared by a

modific.ation of the collagenase method of Kloppenborg
(1.9 68) •

The pooled adrenal eights were transfered
to
.
. a

25 ml .e:i:ylenrneyer flask containing a digesting medium
consisting of KRBG, 40 mg (4%) of bovine serum albumin
(BSA, Sigma Biochemicals, Inc.)

.5 mg of collagenase

(Worthington Biochemical Corp.), and 0. 05 mg DNAase
-{Sigma Biochemicals, Inc •. ).
with a 95%

o~ygen

The flask was equilibrated

- 5% carbon dioxide gas mixture,

stoppered, and incubated at 37°C for 45 minutes in a,
Dubnoff Metabolic Shaking Incubator (Precision
Instruments).

Cells were dispersed with repeated

.excursions with a Pasteur pipet.

The final dige5tan~
I

was filtered through a stainless.steel mesh screen, pore
size 133µ, into a 15 ml polystyrene conical centrifu~e
tube.

The incubation flask was rinsed twice with a O.Sml

portion of KRBG to remove adhering cells and filtered as
'

above.

The filtered digestant was chilled on ice for
'
I

5 minutes and centr:Lfuged for seven minutes at 1820 ;rpm
in a c'iini.cal centrifuge.

I

The supernatant was discarded
I

I.
!

.::6

!
I

and the pellet was washed twice by redispersion in an
I

equal vol1.Illle of KRBG containing 0.1% BSA (KRBGA), wiJth
centrifugations between each wash as described abovJ.
I
The final pellet was dispersed in KRBGA to a
I
I

concentration' of 1 ml per adrenal equivalent.

An al'iquot

of st;spended cells was stained with methylene l:>lue and
counted in a hemocytometer.
Incubations
The cell suspension was midly v.ortexed between each
addition of l'ml aliquots to 25 ml erlenmeyer incubation
flasks.

The final incubation volume was brought to 2 ml

with KRBGA.

All incubations were carried out in a

Dubnoff Metabolic Shaking Incubator at 37°C under an

..

atmosphere of oxygen-95%_ and carbon dioxide - 5%, with
40 .shaking osciilations per minute.
2

hour~_unless

Incubations were for

time course experiments were performed.

Adrenocorticotropic hormone (ACTH, Acthar Injectible
Solution, 40 units, Armour Pharmaceuticals) and the :
'

metabolic inhibitors cycloheximide and actinomycin·Q

(_Sigma Biochemicals, Inc • .l were made. up. in 0; 9% NaCl.
and added directly to the incubates.

A ten minute

preincubation period was allowed for inhibitors prior
to ACTH stimulation;

·-

~
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To determine stimulation of steroidogenic pathways,
2St.. 3 H

pre~nenolone (New England Nuclear, Specific
'

Activity= 17. 2 Ci/mole) in absolute methanol was added

I

to the incubation flasks with or without the.presenc!e of
the inhibitors, cycloheximide or actinomycin D.
To ascertain the identity of the intracellular
mediator.that induces protein synthesis, isolated adrenal
cells with or without cycloheximide were incubated with
2/.. each of [4- 14 c] - cholesterol (New England Nuclear,
Specific Activity = 54 mCi/mmole) in absolute methanol
and L-[3,4,S- 3 H(N)] - leucine (New England Nuclear,
Specific Activity 110 Ci/mmole) in· o. 01 N HCl.

Two

tloses of ACTH, SOOµU and lOµU; dbcAMP (Sigma· Biochemicals,
Inc.), 10

mM~and

73.46 ng, were added to the incubations.

All :lncu.bations were terminated by the addition of
2 ml of reagent grade dichloromethane.

The mixture

~as

swirled and poured into a 12 ml glass conical
centrifuge tube.

Each incubation flask was rinsed with

an additional 2 ml of dichloromethane and the washes'
were added to the original extracts.

The centrifuge

tubes were vortexed for two ten second periods and
centrifuged at 1820 rpm for 10 minutes.
layer .was saved for protein studies.

The aqueous.

An aliquot of :the·

organic phase was transferred to a 5 ml round bottom
culture tube and assayed immediately for precursor

conversion by thin layer chromatography or for
corticosterone by radioi111Illunoassay [RIA) or

i

ca~ped

!
and

I

stored at 4°C until assayed.
)

I

Radioimmunoas's'ay

The RIA procedure was modified from that described
by Endocrine Sciences (Plasma Corticosterone Radioimmunoassay Procedure, 1972).

Briefly, a dilute

antiserum was prepared by adding 10 ml of borate buffer,
pH 8. 0, 151. (1, 2 - 3 H (Nl - corticosterone (New England
Nuclear, Specific Activity= 60 Ci/mmole}, 2001. 0.025%
bovine gamma globulin (Sigma Biochemical Inc.) 2001. 1:0%
bovine serum albumin [Sigma Biochemical Inc.) and 1501.
I
'

corticosterone antiserum (Endocrine Sciences - lot #4..:.4).
•.

One hundred microliters of corticosterone standards

~nd

'

the dichloromethane extracted samples were dried down in
' .
5 ml disposable round bottom culture tubes (12 x 75 mm,
I
I

. Fisher Scientific Co.) in a vacuum oven at 60·°C. to ·~ach
of these RIA tubes ·2501. of dilute·antiserum was added,
I

vortexed for 10 seconds and incubated at room
temperature for 2 hours.

Duplicate 2501. of the

dilu~e

antiserum was also added to 20 ml scintillation vialJ

I

(Fisher Scientific Co.) to determine the radioactive\

I

·counts· per ·antiserum aliquot.

Proteins were precipitated

by addition of 2501. of saturated ammonium sulfate

I

I' - -

.9

supernatant was removed and added to scintillation
fluid formulated by the addition of 19.0 gm 2,5-diphenylox.azole (PPO-scintanalyzed, Fisher) and 1 •.9 gm 1,4bis (5-phenyloxazolyl) benzene (POPOP-scintanalyzed,
Fisher) to 3.8 liters of toluene.

Each vial was

vortexed and counted in a liquid scintillation counter
(Packard Model 2009) for a 10 minute period with counts
per minute recorded.
Thin Layer Chromatography
A 2. 5 ml aliquo.t of the dichloromethane extracts
were dried down under a stream of air, taken up with

-.

acetone, spotted 'on thin layer chromatography (TLC)
plates coated with Selica Gel G (type 60) for TLC
according to Stahl (EM Laboratories Inc.).

Standard's

(l.rng/ml) were spotted in parallel lanes and the plates
were developed in a system of chloroform:
4:1.

ethy.l ether,

Standards were visualized by spraying the TLC

plates with 50% H so and heated until charred.
2 4

~eg~ons

corresponding to the standards were scraped with a
razor blade into a scintillation ·vial.

Ten milliliters

of toluene based scintillation fluid was added and vials
were counted as above.

10

Protein Ass·ay
A 1.5 ml aliquot of the aqueous layer was
transferred to a 5 ml conica.l test tube to which an :equal
volume of cold 20% trichloroacetic acid was added.

.Tubes

were vortexed and centrifuged at 4000 rpm for 10 minutes.
The supernatant was removed and the· pellet washed twice
with 1.5 ml of cold 5% TCA.

The resultant pellet was

then digested with 0.2 ml of scintgest (Fisher Scientific
Co.) at 50°C for one hour.

Two milliliters of toluene

based coiinting fluid was added, and each tube was vortexed
and transferred to a counting vial.

The test tube was

washed-twice with 2 ml of counting fluid.

Final volume of

scintillation fluid in each cuonting vial was brought up

to .10 ml.

'"'=

Statistical Ana·lysis
Data were evaluated by two-paired-sample t test·at
95% confidence level (degree of freedom was four) •
.....

RESULTS

I

The isolation of viable adrenal cells after

.I

!

collagenase digestion produced mean cell counts,.
434,000±61,000.

Using the uptake of methylene blue ~tain

as an indicator for cell viability, it was determined
that 96% of the cells were viable.
A dose·rela:ted release of corticosterone from
isolated adrenal cells is shown in Figure 2.

This

figure shows that the log dose for half maximal
stimulation (Ln 50 ) is

3~

]lU ACTH.

The effect of the transcriptional inhibitor
Actinomycin

~

on ACTH stimulated steroidogenesis in

adrenal cells is. depicted in Figure 3.

At a concentration

of ·4.0 µg/ml, Act D inhibits greater than 98% of
transcription (4).

A dosage of 12. µg/ml Act D produced

no significant change in corticosterone production when
i

compared to non-Act D stimulated ·cells (t

= 0.393) •.

The effect of.varying doses of the protein
translation inhibitor cycloheximide, on steroidogene.sis
was studies.·

Tµe values for the basal release of

corticosterone without cycloheximide and after
cycloheximide addition were 6.05 ng/100,000 cells, and
6.49 ng/100,000 .cells respectively.

'

These values were

shown not to be significantly different (t = O. 709). !
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I .

_Cycloheximide inhibition of ACTH stimulated
steroidogenesis is shown in Figure. 4·.

.

I

'

·rt can be seen

that concentrations 0 .1 µM, 1. 0 µm, and 10 µm of

II
0

cycloheximide produced respective inhibitors of 16%;
35%, and 84% of a 5000 µU dose of ACTH.
To determine the site of cycloheximide inhibition,
3H-pregnenolone (see Figure l.J -was incubated in an
adrenal cell incubation in the presen·ce of 10. 0 µM
cycloheximide and 500 µU of ACTH.

As illustrated in

Figure 5 and neither ACTH alone nor ACTH plus
cycloheximide affected the conversion of pregnenolone to
corticosterone.
To determine activation of protein synthesis by
ACTH and cyclic nucleotides, incubations were prepared
I

of isolated adrenal cells with 3H-leucine and ACTH, I
cAMP ,· dbcAMP, and cGMP (Table 1) •

These experiments

showed significant incorporation of amino acids intd
protein using 500 µU ACTH Ct= 0. 990).

At physiological

levels of.10 µU ACTH and 2 µM cyclic nucleotides, no
amino acid. incorporation was seen.
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Table l~

Response of isolated adrenal cells to
¥arious factors as observed by
H-leucine incorporation into proteins.

Treatment
.

.

. . . .

Mean cpm-3H-leucine

'% Control

'

t-level

..

Control

10,149

-

+ 500µU ACTH

15,597

.154

+ 1. OmM dbcAMP

J,5,495

153

10,880

107

0~040

8,644

85

:0. 990

-+ lOmMcAMP
+ lOmM cGMP

.

*Significantly greater from control (P(.05).

4.310 *
:
*
;3.104
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DISCUSSION
Present concepts of ACTH action are not fully understood.

That ACTH binds to adrenocortical cells and induces

the formation of an intracellular mediator is strongly proposed.

However, whether ·this mediator is cAMP(2,3,4) or

cGMP(l0,11) is still to be determined.

The action of these

cyclic nucleotides is to activate a specific protein kinase
which in turn phosphorylates a regulatory protein (13).

.rt

has been suggested by Garren(8),that this protein induces
the translation of a

-protein

p~etranscribed

mRNA.

The translated

is necessary for the stimulateq conversion of chol-

esterol to Z0,22-hydroxycholesterol(l4).

The present study

adds support to the hypothesis that ACTH action is prior to
the formation of pregnenolone and possesses no apparent
stimulatory properties on the conv·ersion of ,Pregne!lolone to
corticosterone(Figure 5).
Ungar' s lab has, focused the action of ACTH on s,timulating
the transport of cholesterol from the cytoplasmic pools into
the mitochondria(lS).

Supporting experiments by Sharma and

Sawhney(lO) showed that there was no stimulatory effect by.
ACTH, cAMP or cGMP observed on the conversion of cholesterol
to corticosterone in the mitochondria.

This proposed,stimu-

!

lated transport mechanism by ACTH, cAMP and qGMP is shown to

..
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be sensitive to.cycloheximide(Figure 4).

This investigation
I

·showed that Actinomycin D, a transcription inhibitor, did
j

not depress ACTH stimulated steroidogenesis(Figure 3).

This

''

evidence adds support to Garren's hypothesis that there is·
1

a·preformed mRNA which is translated into a protein upon
ACTH stimulation(B).
To evaluate the effects of ACTH, cAMP and cGMP on .protein synthesis, 3H-leucine incorporation into proteins was
studied.

It was determined that ACTH and the lipid:soluable

dbcAMP caused a significant increase

i~

protein

over· that of the control incubate (Table 1).

syn~hesis

However'· cAMP

and cGMP failed to produ~e 3H-leucine incorporation into
proteins.

The stimulation of protein synthesis by dbcAMP
I

but not. cAMP may be explained since the dibutyryl d~rivitive
is more permeable to cell membranes than cAMP, and is less
likely to be degraded by phosphodiesterase(l4).
In summary, this research showed that inhibition of de
-nova synthesis. of mRNA did .not prevent cyclic nucleotide or
ACTH stimulation of corticosterone formation.
duct~on

Also,, the in-

of protein synthesis may occur through the unmasking

of a preformed mRNA.

Finally, pharmacological levels of

both cAMP and cGMP failed to induce amino acid incorporation.
The dibutyryl derivative was effective.

Cycloheximi!de inI'
hibition·of protein synthesis showed that protein synthesis
.I

is needed at a site between cholesterol and pregnena:lone.
I
.
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